If you would like to explore the possibility of participating in a clinical trial at Guthrie, please call 1-800-836-0388.

As a Guthrie cancer patient you will have the unique opportunity to participate in one or more of some 100 clinical research trials that involve new treatments for many cancer types.

As a Guthrie patient you may have the unique opportunity to take part in clinical research trials for atrial fibrillation, congestive heart failure, 脂质紊乱, heart attack and many more cardiology disease states.

As a Guthrie patient you may have an opportunity to take part in clinical research trials for celiac disease, 克罗恩氏病, 溃疡性结肠炎, 返流性疾病, hepatitis and many more gastroenterology disease states.

Clinical trials study new ways to prevent, detect and treat disease. If you take part in research, you help advance new investigational medical therapies. 

标题: S1802, &”;Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard
Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor
in Metastatic Prostate Cancer).&”;
部门: 肿瘤学
诊断: Genito-urinary - Prostate
Principal Investigator: Joyson Poulose, MD
Sub-Investigator (s):
赞助商: NCI
Details (Indentifier #): 03678025
标题: S1827: MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): 一个随机 Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
部门: 肿瘤学
诊断: 肺-小细胞
Principal Investigator: 托马斯·杰格尔，医学博士
赞助商: SWOG
Details (Indentifier #): NCT04155034
标题: S2015: 黑素瘤 Margins Trial (MelMarT): A Phase III, 的多中心, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous 黑素瘤
部门: 肿瘤学
诊断: 黑素瘤
Principal Investigator: David Bertsch, MD, FACS
赞助商: SWOG
Details (Indentifier #): NCT03860883
标题: S2302, PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER
部门: 肿瘤学
诊断: 肺-非小细胞
赞助商: CTSU nci
Details (Indentifier #): NCT05633602
标题: 柳树RNLC3131, 一个随机, 双盲, 安慰剂对照, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C)
部门: 胃肠病学
诊断: Gastrointestinal - Liver
Principal Investigator: Thomas J McDonald, MD
赞助商: 柳树
Details (Indentifier #): NCT05071716
标题: Tethered Enzyme Technology (TET) Assay for
COVID-19检测
部门: 内部研究
诊断: 传染性疾病
Principal Investigator: Sheela Prabhu, MD, FACP
赞助商: 内部FDN
Details (Indentifier #): 没有一个
标题: Tethered Enzyme Technology (TET) Assay for Quantitative Diagnosis of Blunt Head 创伤 (BHT) and Stroke through Detection of Blood and Saliva Biomarkers
部门: 创伤
诊断: 神经学
Principal Investigator: Robert Behm, MD, FACS
Sub-Investigator (s):
赞助商: 内部
Details (Indentifier #): 没有一个
标题: The CHRONICLE Study: A Longitudinal Prospective Observational Study of the Characteristics,Treatment Patterns and Health Outcomes of Individuals with Severe Asthma in the United 状态s, D3250R000023
部门: 肺
诊断: 肺-哮喘
Principal Investigator: 路易斯·R·杜波依斯，医学博士
Sub-Investigator (s):
赞助商: 阿斯特拉捷利康
Details (Indentifier #): NCT03373045
标题: The effect of Epinephrine in Irrigation Fluid for Visualization During Ankle Arthroscopy: 一个随机 Blinded Controlled Trial
部门: 整形外科
诊断: 整形外科
赞助商: 内部
Details (Indentifier #): 没有一个
标题: The Efficacy of Steroid-Sparing Anti-Emetic Therapy in 病人 Treated with High Emetogenic Chemotherapy; Single Center Non-Inferiority Open Label Randomized Controlled Trial
部门: 肿瘤学
诊断: 杂项
Sub-Investigator (s):
赞助商: 内部FDN
Details (Indentifier #): NCT05590923
显示 31-40 of 41 结果